Singapore markets closed

LLY Jan 2026 630.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
31.700.00 (0.00%)
As of 09:55AM EDT. Market open.
Full screen
Previous close31.70
Open31.70
Bid0.00
Ask0.00
Strike630.00
Expiry date2026-01-16
Day's range31.70 - 31.70
Contract rangeN/A
Volume2
Open interestN/A
  • Yahoo Finance Video

    Stocks close higher, Trump tax cuts: Market Domination Overtime

    All three of the major market averages (^GSPC, ^DJI, ^IXIC) ended Monday's session in the green, with the Dow Jones Industrial Average snapping its losing streak and rising by almost half a percent. It continues to fuel the bullish sentiment with multiple financial firms raising their target goal for the S&P 500. Trump-era tax cuts due to expire in late 2025 could take center stage this election, as both leading candidates — sitting President Joe Biden and former President Donald Trump — say they are willing to extend the deadline. Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP-1 weight-loss drugs in high demand. For more expert insight and the latest market action, click here

  • Yahoo Finance Video

    Eli Lilly unveils new North Carolina plant for GLP-1 drugs

    Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP-1 weight-loss drugs in high demand. Yahoo Finance Health Reporter Anjalee Khemlani joins Market Domination Overtime to break down Eli Lilly's investment into the new plant and what it means for the company moving forward. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino

  • Barrons.com

    New Weight-Loss Drugs and Devices Are Coming This Week

    Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.